Erhan Aptullahoglu
Dr Sirintra Nakjang
Dr Jonathan Wallis
Dr Helen Marr
Dr Scott Marshall
et al. | RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia | 2024 |
|
Dr Wei-yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al. | Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x) | 2022 |
|
Dr Timothy Barrow
Dr Laura Woodhouse
Gesa Junge
Dr Susan Tudhope
Dr Jonathan Wallis
et al. | The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy | 2016 |
|
Dr Nicola Sunter
Dr Helen Marr
Dr Andrew Hall
Dr Tryfonia Mainou-Fowler
Professor Graham Jackson
et al. | Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk | 2015 |
|
Dr Sarah Fordham
Dr Helen Marr
Professor James Allan
| Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication | 2013 |
|
Dr Susan Tudhope
Dr Evan Mulligan
Dr Jill Hunter
Dr Helen Marr
Professor barbara Durkacz
et al. | P B S-1086, a "Pan-Rel" Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells | 2012 |
|
